These effects, obtained after only four weeks of treatment, are the first in the field of Down syndrome and represent an important step forward towards the development of a treatment that could ...
A Minnesota nonprofit that supports children with Down syndrome is celebrating a new milestone and a York County mother is ...
The gene DYRK1A could be a potential therapeutic target to treat ‘glue ear’ in people with Down syndrome, according to a new study.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback